Gabapentin Capsule
Product Images NDC 71205-064

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71205-064). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205 064 72

Label for Gabapentin 400 mg capsules by Proficient Rx LP, containing 120 capsules. Each orange and light brown capsule is printed with 'LOGO' and '667'. Manufactured by Watson Pharma Private Limited in India. Includes storage instructions and medication guide notice.*

FDA Label Image

1 (Image 1)

The image displays a formula for calculating creatinine clearance (CLCr). It includes variables such as age in years, weight in kilograms, serum creatinine in mg/dL, and a gender adjustment factor for female patients. This formula is used to estimate kidney function but does not provide additional product or dosage information.*

FDA Label Image

1 (Image 12)

Gabapentin 400 mg oral capsules from Proficient Rx LP in a clear blister pack with five capsules visible. Each capsule is white and oblong-shaped with no visible imprint shown in the image.*

FDA Label Image

1 (Image 2)

Gabapentin 400 mg capsules by Proficient Rx LP in a clear plastic bottle with a white child-resistant cap. The label includes product name, dosage strength, route as oral capsules, and the Proficient Rx LP branding. The bottle contains 100 capsules as indicated on the label.*

FDA Label Image

1 (Image 3)

Gabapentin 400 mg oral capsules by Proficient Rx LP. The clear plastic bottle contains white and opaque capsules, with a white child-resistant cap. The label includes the product name, strength, dosage form, and manufacturer information.*

FDA Label Image

1 (Image 4)

Gabapentin 400 mg oral capsules bottle label from Proficient Rx LP. The white pharmacy bottle features text specifying the medication name, strength, and dosage form prominently on the front.*

FDA Label Image

1 (Image 5)

Chemical structure of Gabapentin, showing a cyclohexane ring with an aminomethyl group and a carboxymethyl group attached to the same carbon.*

FDA Label Image

1 (Image 6)

Line graph showing mean pain scores over an 8-week period, comparing Gabapentin 3600 mg/day versus placebo. The x-axis represents weeks, including a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis represents mean pain scores. Gabapentin shows a decreasing trend in pain scores, whereas placebo remains relatively stable.*

FDA Label Image

2 (Image 7)

A line graph depicting mean pain scores over a 7-week period comparing placebo with gabapentin at 1800 mg/day and 2400 mg/day doses. The x-axis shows weeks with a 3-week dose titration period followed by a 4-week fixed dose period, and the y-axis indicates mean pain score values from 0 to 10.*

FDA Label Image

3 (Image 8)

Bar chart comparing treatment response percentages in two studies. Study 1 shows 12% for placebo (PBO) and 29% for Gabapentin 3600 mg (GBP 3600). Study 2 compares 14% placebo with 32% Gabapentin 1800 mg and 34% Gabapentin 2400 mg. Statistical significance indicated for Gabapentin results with p-values below 0.01 and 0.001.*

FDA Label Image

4 (Image 9)

A scatter plot showing the difference percentage against daily dose (mg) for Gabapentin. Data points represent three studies (a, b, and c) at doses of 600, 900, 1200, and 1800 mg. Study a is marked by black squares, study b by gray squares, and study c by white squares, illustrating comparative difference percentages across doses.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.